期刊文献+

MRI联合^(18)F-FDG PET和^(11)C-MET PET对颅内肿胀性脱髓鞘病变与胶质瘤的鉴别诊断作用 被引量:4

MRI combined with ^(18)F-FDG PET and^(11)C-MET PET in differentiating tumefactive demyelinating lesion and glioma
下载PDF
导出
摘要 目的探讨MRI联合^(18)F-脱氧葡萄糖(^(18)F-FDG)PET和^(11)C-蛋氨酸(^(11)C-MET)PET显像对颅内肿胀性脱髓鞘病变与胶质瘤的鉴别诊断价值。方法纳入经病理学直接证实或内科保守治疗间接证实的14例颅内肿胀性脱髓鞘病变患者和17例胶质瘤患者,采用MRI观察病变与周围正常脑组织界限,T1WI、T2WI和扩散加权成像(DWI)信号强度,强化征象(包括环状强化和开环状强化等),占位效应,周围脑水肿,病变中心静脉扩张,胼胝体受累,病变中心坏死,灰质受累情况;^(18)F-FDG PET和^(11)C-MET PET显像对代谢程度进行视觉分析。结果 MRI显示,颅内肿胀性脱髓鞘病变患者占位效应0级8例(8/14)、Ⅰ级4例(4/14)、Ⅱ级1例(1/14)、Ⅲ级1例(1/14),周围脑水肿Ⅰ度12例(12/14)、Ⅱ度2例(2/14);胶质瘤患者占位效应0级2例(2/17)、Ⅰ级6例(6/17)、Ⅱ级7例(7/17)、Ⅲ级2例(2/17),周围脑水肿Ⅰ度7例(7/17)、Ⅱ度10例(10/17),组间差异均有统计学意义(Fisher确切概率法:P=0.032,0.024)。^(18)F-FDG PET和^(11)C-MET PET显像对颅内肿胀性脱髓鞘病变与胶质瘤的鉴别诊断差异无统计学意义(Fisher确切概率法:P=0.182,0.081)。结论 MRI显示的占位效应和周围脑水肿可以用于鉴别诊断颅内肿胀性脱髓鞘疾病与胶质瘤,PET-CT对症状类似胶质瘤的颅内肿胀性脱髓鞘病变无明确诊断价值。 Objective To explore the value of MRI combined with 18F-fluoro-2-deoxy-D-glucose (18F-FDG) PET and 11C-methionine (11C-MET) PET on differentiating tumefactive demyelinating lesion (TDL) and glioma.Methods Fourteen cases of TDL and 17 cases of glioma were confirmed by pathology directly or internal medicine treatment.MRI was used to observe the lesion boundary,T1WI,T2WI and diffusion weighted imaging (DWI) signal intensity,enhancement (including ring enhancement and open-ring enhancement,etc.),mass effect,peripheral edema,and the presence of central venectasia,corpus callosum engagement,central necrosis and gray matter engagement.18F-FDG PET and 11C-MET PET were used to calculate relative uptake values.Results Among all TDL cases,MRI showed that mass effect of 8 cases (8/14) were grade 0,4 cases (4/14) grade Ⅰ,one case (1/14) was grade Ⅱ and one case (1/14) gradeⅢ;the peripheral edema of 12 cases (12/14) were grade Ⅰ and 2 cases (2/14) grade Ⅱ.Among all glioma cases,the mass effect of 2 cases (2/17) were grade 0,6 cases (6/17) grade Ⅰ,7 cases (7/17) grade Ⅱ and 2 cases (2/17) grade m;the peripheral edema of 7 cases (7/17) were grade Ⅰ and 10 cases (10/17) grade Ⅱ.The differences between TDL and glioma were statistically significant (Fisher's exact probability:P =0.032,0.024).18F-FDG PET and 11C-MET PET were not statistically significant in differentiating TDL and glioma (Fisher's exact probability:P =0.182,0.081).Conclusions Mass effect and peripheral edema showed in MRI can be used for the differential diagnosis of TDL and glioma.The value of PET-CT in differentiating TDL and glioma is unsure.
作者 杨亦寒 蔡莉 马海文 王颖 白宇 明浩朗 于圣平 任炳成 林雨 张凯 海龙 王伟 程铖 李涛 杨学军 YANG Yi-han;CAI Li;MA Hai-wen;WANG Ying;BAI Yu;MING Hao-lang;YU Sheng-ping;REN Bing-cheng;LIN Yu;ZHANG Kai;HAI Long;WANG Wei;CHENG Cheng;LI Tao;YANG Xue-jun(Department of Neurosurgery, 2PET-CT Center, Tianjin Medical University General Hospital, Tianjin 300052, Chin)
出处 《中国现代神经疾病杂志》 CAS 2017年第10期754-761,共8页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 中国抗癌协会神经肿瘤专业委员会神经肿瘤研究项目(项目编号:CSNO-2014-MSD01)~~
关键词 脱髓鞘疾病 中枢神经系统 神经胶质瘤 磁共振成像 体层摄影术 发射型计算机 Demyelinating diseases Central nervous system Glioma Megnetic resonance imaging Tomography,emission-computed
  • 相关文献

参考文献2

二级参考文献23

  • 1Bot JC, Barkhof F, Lycklamaia Nijehoh G, van Schaardenburg D, Voskuyl AE, Ader HJ, Pijnenburg JA, Polman CH, Uitdehaag BM, Vermeulen EG, Castelijns JA. Differentiation of multiple sclerosis from other inflammatory disorders and eerebrovascular disease: value of spinal MR imaging. Radiology, 2002, 223:46-56.
  • 2Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica arid recurrent longitudinal extensive myelitis. J Neuroradiol, 2009, 36:199-205.
  • 3Kim DH, Kim JH, Choi SH, Sohn CH, Yun TJ, Kim CH, Chang KH. Differentiation between intramedullary spinal ependymoma and astrocytoma: comparative MRI analysis. Clin Radiol, 2014, 69:29-35.
  • 4Brinar M, Rados M, Habek M, Poser CM. Enlargement of the spinal cord: inflammation or neoplasm? Clin Neurol Neurosurg, 2006, 108:284-289.
  • 5Bot JC, Barkhof F, Polman CH, Lycklama a Nijehoh GJ, De Groot V, Bergers E, Ader H.I, Castelijns .IA. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology, 2004, 62:226-233.
  • 6Cohen - Gadol AA, Zikel OM, Miller GM, Aksamit AJ, Scheithauer BW, Krauss WE. Spinal cord biopsy: a review of 38 cases. Neurosurgery, 2003, 52:806-815.
  • 7Yaghi S, Gokdin M, Sethi H. Tumefactive demyelination of the spinal cord. Acta Nearol Belg, 2010, 110:206-208.
  • 8Sadaka Y, Verhey LH, Shroff MM, Branson HM, Arnold DL, Narayanan S, Sled JG, Bar-Or A, Sadovnick AD, McGowan M, Marrie RA, Banwell B; Canadian Pediatric DemyelinatingDisease Network. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol, 2012, 72:211-223.
  • 9Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66:1485-1489.
  • 10Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology, 2002, 59:499-505.

共引文献42

同被引文献28

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部